MSF Field Research > 1 Published Research and Commentary > TB > Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India.

Please use this identifier to cite or link to this item: http://hdl.handle.net/10144/235558
    Del.icio.us     LinkedIn     Citeulike     Connotea     Facebook     Stumble it!


Download this article:
View/Open File Description Size Format
Thumbnail
View/Open
18 . Issikidas P et al MDR TB side effects PlosOne.pdf86KbAdobe PDF

Title: Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India.
Authors: Isaakidis, Petros
Varghese, Bhanumati
Mansoor, Homa
Cox, Helen S
Ladomirska, Joanna
Saranchuk, Peter
Da Silva, Esdras
Khan, Samsuddin
Paryani, Roma
Udwadia, Zarir
Migliori, Giovanni Battista
Sotgiu, Giovanni
Reid, Tony
Affiliation: Médecins Sans Frontières, Mumbai, India.
Citation: Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India. 2012, 7 (7):e40781 PLoS ONE
Publisher: PLoS
Journal: PloS One
Issue Date: Jul-2012
URI: http://hdl.handle.net/10144/235558
DOI: 10.1371/journal.pone.0040781
PubMed ID: 22792406
Abstract: Significant adverse events (AE) have been reported in patients receiving medications for multidrug- and extensively-drug-resistant tuberculosis (MDR-TB & XDR-TB). However, there is little prospective data on AE in MDR- or XDR-TB/HIV co-infected patients on antituberculosis and antiretroviral therapy (ART) in programmatic settings.
Language: en
ISSN: 1932-6203
Rights: Published by Public Library of Science, http://www.plosone.org/ Archived on this site by Open Access permission
Appears in topics: TB

Related articles on PubMed
bullet
Ambulatory multi-drug resistant tuberculosis treatment outcomes in a cohort of HIV-infected patients in a slum setting in Mumbai, India.
Isaakidis P, Cox HS, Varghese B, Montaldo C, Da Silva E, Mansoor H, Ladomirska J, Sotgiu G, Migliori GB, Pontali E, Saranchuk P, Rodrigues C, Reid T
2011
bullet
bullet
Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care.
Brust JC, Shah NS, Scott M, Chaiyachati K, Lygizos M, van der Merwe TL, Bamber S, Radebe Z, Loveday M, Moll AP, Margot B, Lalloo UG, Friedland GH, Gandhi NR
2012 Aug
bullet
bullet
Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting.
Gandhi NR, Andrews JR, Brust JC, Montreuil R, Weissman D, Heo M, Moll AP, Friedland GH, Shah NS
2012 Jan
See all 154 articles

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.

 

OR Logo Powered by Open Repository | Cookies

My MSF

MSF logo MSF Field Research

May 22, 2013